SleepWell Trade

Trend-Following Backtester · Guide · backtest 한국어

equity · US

Galectin Therapeutics Inc. backtest

10 trend-following strategies were compared on the full daily history of Galectin Therapeutics Inc.. 10 beat buy-and-hold CAGR; ADX / DI 방향성 ranks first by Sharpe, matching the main backtester.

Data 2002-09-04 ~ 2026-07-31daily bars 6,015 (23.9 years)Costs 0.5%Venue XNASMonthly snapshot 2026-07-31

Results by strategy

10 of 10 beat buy and hold (CAGR -5.7%, drawdown -99.0%).

Sharpe leader (same as main): ADX / DI 방향성 — CAGR 12.3%, MDD -86.4%, Sharpe 0.47, 23% exposure.

No strategy retained at least 75% of buy-and-hold CAGR while reducing drawdown by both 20% relatively and 5 percentage points absolutely.

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
ADX / DI 방향성
period=8, threshold=34
12.3%-86.4%0.470.1416.1x28623%
Parabolic SAR
step=0.015, maxStep=0.1
4.2%-95.2%0.410.042.7x32841%
Donchian 채널 돌파
entryN=13, exitN=67
-3.1%-98.1%0.37-0.030.5x7775%
볼린저 밴드 돌파
n=42, k=2.6
5.9%-85.8%0.360.074.0x8222%
MACD
fast=16, slow=26, signal=14
-0.9%-95.1%0.35-0.010.8x33650%
ROC 모멘텀
n=32, threshold=0.09
2.6%-86.4%0.340.031.9x37731%
Keltner 채널 돌파
emaPeriod=19, atrPeriod=14, mult=1.3
1.4%-91.2%0.320.021.4x20424%
Supertrend
period=11, mult=4.7
-4.4%-97.7%0.31-0.040.3x6955%
SMA 크로스오버
fast=31, slow=219
-5.4%-95.0%0.21-0.060.3x4144%
EMA 크로스오버
fast=61, slow=184
-5.2%-96.1%0.20-0.050.3x3342%
Buy and hold-5.7%-99.0%0.44-0.060.2x1100%
0.1 1x 10x 2003 2006 2009 2012 2015 2018 2021 2024 ADX / DI 방향성Buy and hold
ADX / DI 방향성: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -25% -50% -74% -99% 2003 2006 2009 2012 2015 2018 2021 2024 Buy and holdADX / DI 방향성
ADX / DI 방향성 maximum drawdown -86.4% (2011-01-18 → 2016-09-29), recovered after 5,343 days.

Rules of the top strategy

Looks at both the direction and the strength of the trend; holds only in a strong uptrend.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 40 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupMore US assetsAll asset reports

Read next